Literature DB >> 16005857

Comparative analysis of the neuronal activation and cardiovascular effects of nitroglycerin, sodium nitroprusside and L-arginine.

Cristina Tassorelli1, Rosaria Greco, Donata Cappelletti, Giorgio Sandrini, Giuseppe Nappi.   

Abstract

In this study, we compare the biological effects, Fos expression and cardiovascular responses induced in the rat, of different nitric oxide modulators (nitroglycerin, sodium nitroprusside and L-arginine). Nitroglycerin and sodium nitroprusside induced a similar pattern of neuronal activation in several areas, which include the paraventricular and supraoptic nuclei of the hypothalamus, central nucleus of the amygdala, parabrachial nucleus, locus coeruleus, ventrolateral medulla and nucleus tractus solitarius. However, only nitroglycerin activated the periaqueductal grey and nucleus trigeminalis caudalis. L-arginine-induced neuronal activation was restricted to the paraventricular and supraoptic nuclei of the hypothalamus. As regards cardiovascular effect, both nitroglycerin and sodium nitroprusside induced moderate hypotension (nitroglycerin: -23.3%, sodium nitroprusside: -24.3%) that lasted 40 min in the case of sodium nitroprusside and 80 min in the case of nitroglycerin. L-arginine did not significantly influence blood pressure. These data suggest that nitroglycerin, sodium nitroprusside and L-arginine are associated with different biological effects on both the central nervous system and the cardiovascular system. Of the NO-related drugs tested in this study, only nitroglycerin confirmed its ability to activate brainstem areas implicated in nociception.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16005857     DOI: 10.1016/j.brainres.2005.05.067

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Inhibition of the PKCγ-ε pathway relieves from meningeal nociception in an animal model: an innovative perspective for migraine therapy?

Authors:  Nicoletta Galeotti; Carla Ghelardini
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

Review 2.  The peripheral corticotropin-releasing factor (CRF)-induced analgesic effect on somatic pain sensitivity in conscious rats: involving CRF, opioid and glucocorticoid receptors.

Authors:  Natalia I Yarushkina; Ludmila P Filaretova
Journal:  Inflammopharmacology       Date:  2018-02-05       Impact factor: 4.473

3.  Increase in trigeminal ganglion neurons that respond to both calcitonin gene-related peptide and pituitary adenylate cyclase-activating polypeptide in mouse models of chronic migraine and posttraumatic headache.

Authors:  Zhaohua Guo; Katherine Czerpaniak; Jintao Zhang; Yu-Qing Cao
Journal:  Pain       Date:  2021-05-01       Impact factor: 7.926

4.  Pharmacology of reflex blinks in the rat: a novel model for headache research.

Authors:  M G Jones; A P Andreou; S B McMahon; D Spanswick
Journal:  J Headache Pain       Date:  2016-10-21       Impact factor: 7.277

5.  Peripheral Sensory Neurons Expressing Melanopsin Respond to Light.

Authors:  Anna Matynia; Eileen Nguyen; Xiaoping Sun; Frank W Blixt; Sachin Parikh; Jason Kessler; Luis Pérez de Sevilla Müller; Samer Habib; Paul Kim; Zhe Z Wang; Allen Rodriguez; Andrew Charles; Steven Nusinowitz; Lars Edvinsson; Steven Barnes; Nicholas C Brecha; Michael B Gorin
Journal:  Front Neural Circuits       Date:  2016-08-10       Impact factor: 3.492

6.  PKC-Dependent Signaling Pathways within PAG and Thalamus Contribute to the Nitric Oxide-Induced Nociceptive Behavior.

Authors:  Nicoletta Galeotti; Carla Ghelardini
Journal:  ISRN Pain       Date:  2013-08-21

7.  Chronic and intermittent administration of systemic nitroglycerin in the rat induces an increase in the gene expression of CGRP in central areas: potential contribution to pain processing.

Authors:  Rosaria Greco; Chiara Demartini; Anna Maria Zanaboni; Cristina Tassorelli
Journal:  J Headache Pain       Date:  2018-07-13       Impact factor: 7.277

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.